Esophageal Cancer Clinical Trial

A Systems Approach to Immunotherapy Biomarker Identification Within the Postoperative Wound-Healing Microenvironment in Patients With Gastroesophageal Cancer

Summary

The purpose of this research is to collect surgical drain fluid and blood from patients who have undergone surgery for gastric or esophageal cancer, and to analyze the fluid and blood using a variety of laboratory techniques for molecular markers capable of predicting response to immunotherapy.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients undergoing esophagectomy or gastrectomy for gastroesophageal cancer.
Adult males and females at least 18 years of age
Ability to complete testing in the protocol and attend study visits
Able and willing to consent to protocol
Adequate organ function Absolute Neutrophil Count (ANC) ≥1.5 x 103/μL Platelets ≥100 x 103/μL Hemoglobin >9.0 g/dL Total Bilirubin (3 g/dL Creatinine ≤1.5 mg/dL

Exclusion Criteria:

Female patients who are pregnant or breast-feeding
Concomitant illness that would prevent adequate patient assessment or in the investigators' opinion pose an added risk for study participants.
Life-threatening intercurrent illness
Anticipated poor compliance
Prisoners or subjects who are involuntarily incarcerated
Persons with decisional incapacity/cognitive impairment
Any history or evidence of severe illness or any other condition that would make the patient, in the opinion of the investigator unsuitable for the study
Subject is enrolled in a separate interventional clinical trial

Study is for people with:

Esophageal Cancer

Estimated Enrollment:

10

Study ID:

NCT05338060

Recruitment Status:

Recruiting

Sponsor:

Inova Health Care Services

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Inova Schar Cancer Institute
Fairfax Virginia, 22031, United States More Info
Keary Janet, BS
Contact
571-472-0224
[email protected]
Stephanie Van Bebber, MSc
Contact
571-472-0213
[email protected]
Raymond Wadlow, MD
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Esophageal Cancer

Estimated Enrollment:

10

Study ID:

NCT05338060

Recruitment Status:

Recruiting

Sponsor:


Inova Health Care Services

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.